Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-010810

Chief Operating Officer gave up 744 shares (to pay taxes)

  • Chief Operating Officer acquired 1,791 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cittadine Andrew Chief Operating Officer 2025-03-31 Option exercise +1,791 42,729 D
Cittadine Andrew Chief Operating Officer 2025-03-31 Shares withheld for taxes −744 $36.41 $27,089 41,985 D
Derivatives
Cittadine Andrew Chief Operating Officer 2024-03-31 Option exercise · Restricted Stock Units −1,791 49,864 D
Loading xslF345X05/rdgdoc.xml…